Loading clinical trials...
Loading clinical trials...
Nonmyeloablative Conditioning With Pre- and Post-Transplant Rituximab Followed by Related or Unrelated Donor Hematopoietic Cell Transplantation for Patients With Advanced Chronic Lymphocytic Leukemia: A Multi-Center Trial
Conditions
Interventions
Allogeneic Hematopoietic Stem Cell Transplantation
Cyclosporine
+7 more
Locations
5
United States
Mayo Clinic
Rochester, Minnesota, United States
VA Puget Sound Health Care System
Seattle, Washington, United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Rigshospitalet University Hospital
Copenhagen, Denmark
University of Torino
Torino, Italy
Start Date
December 1, 2004
Primary Completion Date
March 30, 2018
Completion Date
March 30, 2018
Last Updated
July 11, 2019
NCT06846671
NCT07218341
NCT06548152
NCT07030400
NCT05006716
NCT07277231
Lead Sponsor
Fred Hutchinson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions